Key Information on NIOX Group Plc's Securities Disclosure
The public disclosure of interests in relevant securities represents a crucial aspect of maintaining transparency within financial markets. NIOX Group Plc, known for its innovative approaches to respiratory diagnostics, is subject to these regulations which help ensure equitable treatment of investors and stakeholders.
Who is Involved in the Disclosure?
Full Name of Discloser
The discloser in this instance is Rathbones Group Plc. This entity plays a vital role as it holds significant interests in the securities of NIOX Group Plc, showcasing the interconnectedness of investment firms with public entities.
Interest Holder's Identity
If the holder of interests differs from Rathbones Group Plc, further disclosures are required. It is essential to maintain clarity regarding who controls these interests. If a trust is the involved party, specifics regarding trustees and beneficiaries must be disclosed.
The Nature of the Offeror and Offer Products
Identifying NIOX Group Plc
This disclosure specifically relates to NIOX Group Plc, emphasizing the need for regular updates about securities in which substantial interests exist. Transparency aids stakeholders in making informed decisions about their investments.
Current Investment Position
Rathbones holds a total of 34,312,187 ordinary shares of 0.08p in NIOX Group Plc, translating to an ownership percentage of approximately 8.62%. This kind of detailed reporting is pivotal, as significant ownership stakes can affect decision-making at the corporate level.
Transactions Involving Securities
Recent Dealings
Recent transactions reveal that Rathbones Group Plc has engaged in selling and purchasing activities. Specifically, they have sold 45,880 shares at 74.26p each, showcasing active trading patterns. Additionally, a purchase of 2,760 shares at a slightly adjusted price indicates an ongoing commitment to NIOX Group Plc.
Cash-Settled Derivatives and Other Transactions
No significant cash-settled derivatives or stock-settled transactions have been reported, as noted by the lack of entries in those categories. This can suggest a focused investment strategy by Rathbones in the context of NIOX Group Plc, favoring straightforward investment over more complex financial instruments.
Other Relevant Disclosures
Indemnity Arrangements
The documentation clarifies that there are currently no indemnity arrangements or agreements that might act as an inducement for either party in the transaction. Keeping a clean record aids in mitigating misunderstandings between impacted stakeholders.
Agreements on Options or Derivatives
To further clarify any dealings, it has been stated that there are no existing agreements regarding voting rights or securities acquisitions concerning derivatives. This lack of engagement in such agreements ensures straightforward governance without conflicts of interest.
Conclusion
As all disclosures are aimed at adhering to regulatory obligations, they help uphold market integrity. NIOX Group’s engagement with Rathbones Group reflects a transparent relationship with key investors, promoting a healthy investment environment. It is essential for investors to stay informed about how these disclosures influence their stakes in the company.
Frequently Asked Questions
What is the purpose of the disclosure document?
The disclosure document serves to inform the market about any significant holdings in a company, fostering transparency and compliance with regulatory standards.
Who is Rathbones Group Plc?
Rathbones Group Plc is an investment firm that manages assets for various clients, playing a crucial role in the investment ecosystem.
What kind of shares does NIOX Group Plc issue?
NIOX Group Plc issues ordinary shares with a nominal value of 0.08p, which are publicly traded on the London Stock Exchange.
How often must disclosures be made?
Disclosures must be made whenever there are significant changes in holdings that exceed predetermined thresholds set by regulatory bodies.
Who can be contacted for more information?
For additional details, Chinwe Enyi from the Compliance Department is available as the primary contact for investor-related inquiries.
